Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.25.1.2 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.409ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.83ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.310ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.362.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.162ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Y.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.86ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.154ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.4.8ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.2.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.41ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.137ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.446ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.76 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.398ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.163ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
P.3 (Theta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.38.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAVENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.4.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBC.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.4.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.20ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.77ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.513ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.338ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.284ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.9.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.498ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.184ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.187ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
D.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AE.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.110.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.342ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.500ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.511ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.428.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.506ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.482ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.335ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.499.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.116ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.134ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.393ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.381ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used